Harbin Gloria Pharmaceuticals Co., Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Harbin Gloria Pharmaceuticals Co., Ltd with three other
companies in this sector in CHINA :
sales of 5.32 billion Chinese Renmimbi [US$779.31 million]
of which 100%
Zhejiang Huahai Pharmaceutical
(5.39 billion Chinese Renmimbi [US$789.57 million]
of which 48%
was Drug Sale), and
FUREN Group Pharmaceutical Co Ltd
(5.17 billion Chinese Renmimbi [US$757.58 million]
of which 83%
was Pharmaceutical Industry).
Harbin Gloria Pharmaceuticals Co., Ltd reported sales of 5.05 billion Chinese Renmimbi (US$740.59 million)
December of 2019.
decrease of 7.8%
versus 2018, when the company's sales were 5.48 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 11.5% decline
in Pharmaceutical Agents, from 1.03 billion Chinese Renmimbi to 907.60 million Chinese Renmimbi.
There were also decreases in sales in
Pharmaceutical Manufacturing (down 7.0% to 4.12 billion Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Other (up 569.1% to 30.93 million Chinese Renmimbi)